Live feed04:00:00·6dSave storyPRReleasevia QuantisnowPhase III Trial Shows Veracyte’s Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate CancerByQuantisnow·Wall Street's wire, on your screen.VCYTVeracyte Inc.Health Care